+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Female Infertility Diagnosis & Treatment Market by Treatment Method, Diagnosis Technique, Distribution Channel - Global Forecast to 2030- Product Image
Female Infertility Diagnosis & Treatment Market by Treatment Method, Diagnosis Technique, Distribution Channel - Global Forecast to 2030- Product Image
Sale

Female Infertility Diagnosis & Treatment Market by Treatment Method, Diagnosis Technique, Distribution Channel - Global Forecast to 2030

  • PDF Icon

    Report

  • 194 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5977741
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The female infertility diagnosis and treatment market is evolving rapidly as shifting demographics, expanding patient expectations, and digital innovations intensify demands for advanced, accessible fertility solutions. Senior decision-makers face a landscape shaped by regulatory changes, technology advances, and emerging competitive pressures.

Market Snapshot: Female Infertility Diagnosis & Treatment Market

The Female Infertility Diagnosis & Treatment Market grew from USD 1.96 billion in 2024 to USD 2.12 billion in 2025. It is expected to continue growing at a CAGR of 8.16%, reaching USD 3.14 billion by 2030. This expansion is driven by a convergence of technological innovation, heightened patient awareness, and growing demand for personalized fertility solutions globally. The competitive environment is becoming more dynamic as key players expand pipelines, integrate new diagnostic approaches, and enhance their service offerings in response to evolving clinical and regulatory landscapes.

Scope & Segmentation

  • Treatment Method: Assisted reproductive technologies (ART), cryopreservation platforms, fertility medications, and surgical interventions address a broad spectrum of patient needs.
  • Diagnosis Technique: Comprehensive diagnostics include blood-based hormone assays, genetic testing, imaging modalities, hysterosalpingography, and laparoscopy.
  • Distribution Channel: Fertility solutions are delivered through general gynecology clinics, specialized fertility centers, hospital services (private and public), home care testing, and independent laboratories.
  • Geographic Regions: Coverage spans the Americas (United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including the United Kingdom, Germany, France, Russia, UAE, South Africa, and more), and Asia-Pacific (China, India, Japan, Australia, South Korea, among others).
  • Key Companies: Notable players are Merck KGaA, Ferring B.V., Gedeon Richter Plc, CooperCompanies, Vitrolife AB, Cook Medical, Progyny, Igenomix, Illumina, and Hamilton Thorne.

Key Takeaways

  • Growth is underpinned by increasing maternal age, environmental influences, and greater patient education, motivating demand for highly specialized diagnostic and therapeutic fertility services.
  • Technological transformation—including artificial intelligence, precision medicine, and telehealth platforms—enhances diagnostic accuracy, accelerates decision-making, and improves access to care both in urban and remote settings.
  • Regulatory adaptations have encouraged rapid approval of innovative therapies and supported integration of telemedicine, allowing clinics to streamline patient pathways and care delivery.
  • Personalized approaches dominate, with fertility regimens tailored using hormonal, genetic, and lifestyle information, moving away from standardized models in favor of individualized protocols.
  • Providers and laboratories are forming new partnerships to optimize logistics, share operational risks, and differentiate through advanced data analytics and patient engagement tools.
  • Market participants must maintain agility, balancing the demands of regulatory compliance, technological adoption, and emerging business models to sustain growth and competitiveness.

Tariff Impact

Recent U.S. tariffs on laboratory instruments and medical devices have disrupted cost structures and supply chains, driving fertility providers to pursue more localized sourcing and restructured procurement strategies. Short-term logistical challenges have been partially offset by expanded domestic manufacturing, but the need for ongoing risk mitigation remains high for clinics and suppliers alike.

Methodology & Data Sources

This research utilizes a robust, multi-phase methodology integrating peer-reviewed literature, regulatory filings, and industry reports. Primary research included comprehensive interviews with clinicians, laboratory leads, payers, and key industry executives to validate findings and illuminate adoption barriers. All data points were cross-verified through triangulation, while quantitative benchmarks and regional trend analyses were supported by expert review.

Why This Report Matters

  • Informs strategic investments by detailing segment-specific growth drivers, technology adoption, and regional variations critical for optimizing resource allocation.
  • Equips decision-makers with actionable market intelligence to navigate complex regulatory environments and rapidly shifting competitive dynamics.
  • Enables robust risk mitigation and value chain optimization in the context of volatile tariffs and global supply chain disruptions.

Conclusion

As patient needs and competitive dynamics evolve, senior leaders gain a multidimensional view of risks and opportunities from this report. Informed strategy will enable stakeholders to proactively adapt, foster innovation, and secure a leading position within the female infertility diagnosis and treatment market.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Female Infertility Diagnosis & Treatment Market, by Treatment Method
8.1. Introduction
8.2. Assisted Reproductive Technology
8.2.1. Gamete Intrafallopian Transfer
8.2.2. in Vitro Fertilization
8.2.3. Intracytoplasmic Sperm Injection
8.2.4. Intrauterine Insemination
8.3. Cryopreservation
8.3.1. Embryo Cryopreservation
8.3.2. Oocyte Cryopreservation
8.3.3. Sperm Cryopreservation
8.4. Fertility Medications
8.4.1. Clomiphene Citrate
8.4.2. Gonadotropins
8.4.3. Letrozole
8.5. Surgical Intervention
8.5.1. Hysteroscopic Surgery
8.5.2. Laparoscopic Surgery
8.5.3. Myomectomy
8.5.4. Tubal Surgery
9. Female Infertility Diagnosis & Treatment Market, by Diagnosis Technique
9.1. Introduction
9.2. Blood Diagnostics
9.2.1. Anti Mullerian Hormone Test
9.2.2. Follicle Stimulating Hormone Test
9.2.3. Luteinizing Hormone Test
9.2.4. Prolactin Test
9.3. Genetic Testing
9.3.1. Cystic Fibrosis Transmembrane Conductance Regulator Testing
9.3.2. Karyotyping
9.3.3. Y Chromosome Microdeletion Analysis
9.4. Hysterosalpingography
9.5. Laparoscopy
9.6. Ultrasound Imaging
9.6.1. Doppler Ultrasound
9.6.2. Transvaginal Ultrasound
10. Female Infertility Diagnosis & Treatment Market, by Distribution Channel
10.1. Introduction
10.2. Clinic Services
10.2.1. General Gynecology Clinics
10.2.2. Specialized Fertility Clinics
10.3. Home Care Testing
10.3.1. At Home Hormone Kits
10.3.2. Remote Telehealth Services
10.4. Hospital Services
10.4.1. Private Hospitals
10.4.2. Public Hospitals
10.5. Independent Laboratories
10.5.1. Accredited Labs
10.5.2. Non Accredited Labs
11. Americas Female Infertility Diagnosis & Treatment Market
11.1. Introduction
11.2. United States
11.3. Canada
11.4. Mexico
11.5. Brazil
11.6. Argentina
12. Europe, Middle East & Africa Female Infertility Diagnosis & Treatment Market
12.1. Introduction
12.2. United Kingdom
12.3. Germany
12.4. France
12.5. Russia
12.6. Italy
12.7. Spain
12.8. United Arab Emirates
12.9. Saudi Arabia
12.10. South Africa
12.11. Denmark
12.12. Netherlands
12.13. Qatar
12.14. Finland
12.15. Sweden
12.16. Nigeria
12.17. Egypt
12.18. Turkey
12.19. Israel
12.20. Norway
12.21. Poland
12.22. Switzerland
13. Asia-Pacific Female Infertility Diagnosis & Treatment Market
13.1. Introduction
13.2. China
13.3. India
13.4. Japan
13.5. Australia
13.6. South Korea
13.7. Indonesia
13.8. Thailand
13.9. Philippines
13.10. Malaysia
13.11. Singapore
13.12. Vietnam
13.13. Taiwan
14. Competitive Landscape
14.1. Market Share Analysis, 2024
14.2. FPNV Positioning Matrix, 2024
14.3. Competitive Analysis
14.3.1. Merck KGaA
14.3.2. Ferring B.V.
14.3.3. Gedeon Richter Plc
14.3.4. CooperCompanies, Inc.
14.3.5. Vitrolife AB
14.3.6. Cook Medical LLC
14.3.7. Progyny, Inc.
14.3.8. Igenomix S.L.
14.3.9. Illumina, Inc.
14.3.10. Hamilton Thorne, Ltd.
15. ResearchAI
16. ResearchStatistics
17. ResearchContacts
18. ResearchArticles
19. Appendix
List of Figures
FIGURE 1. FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET MULTI-CURRENCY
FIGURE 2. FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET MULTI-LANGUAGE
FIGURE 3. FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT METHOD, 2024 VS 2030 (%)
FIGURE 8. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT METHOD, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT METHOD, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY GAMETE INTRAFALLOPIAN TRANSFER, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY IN VITRO FERTILIZATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY INTRACYTOPLASMIC SPERM INJECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY INTRAUTERINE INSEMINATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CRYOPRESERVATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY EMBRYO CRYOPRESERVATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY OOCYTE CRYOPRESERVATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY SPERM CRYOPRESERVATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CRYOPRESERVATION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY FERTILITY MEDICATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CLOMIPHENE CITRATE, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY GONADOTROPINS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY LETROZOLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY FERTILITY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY SURGICAL INTERVENTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY HYSTEROSCOPIC SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY LAPAROSCOPIC SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY MYOMECTOMY, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TUBAL SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY SURGICAL INTERVENTION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY BLOOD DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY ANTI MULLERIAN HORMONE TEST, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY FOLLICLE STIMULATING HORMONE TEST, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY LUTEINIZING HORMONE TEST, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PROLACTIN TEST, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY BLOOD DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY GENETIC TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY KARYOTYPING, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY Y CHROMOSOME MICRODELETION ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY GENETIC TESTING, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY HYSTEROSALPINGOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY LAPAROSCOPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY ULTRASOUND IMAGING, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DOPPLER ULTRASOUND, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TRANSVAGINAL ULTRASOUND, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY ULTRASOUND IMAGING, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CLINIC SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY GENERAL GYNECOLOGY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY SPECIALIZED FERTILITY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CLINIC SERVICES, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY HOME CARE TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY AT HOME HORMONE KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY REMOTE TELEHEALTH SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY HOME CARE TESTING, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY HOSPITAL SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY HOSPITAL SERVICES, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY INDEPENDENT LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY ACCREDITED LABS, BY REGION, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY NON ACCREDITED LABS, BY REGION, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY INDEPENDENT LABORATORIES, 2018-2030 (USD MILLION)
TABLE 64. AMERICAS FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT METHOD, 2018-2030 (USD MILLION)
TABLE 65. AMERICAS FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 66. AMERICAS FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CRYOPRESERVATION, 2018-2030 (USD MILLION)
TABLE 67. AMERICAS FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY FERTILITY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 68. AMERICAS FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY SURGICAL INTERVENTION, 2018-2030 (USD MILLION)
TABLE 69. AMERICAS FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 70. AMERICAS FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY BLOOD DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 71. AMERICAS FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY GENETIC TESTING, 2018-2030 (USD MILLION)
TABLE 72. AMERICAS FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY ULTRASOUND IMAGING, 2018-2030 (USD MILLION)
TABLE 73. AMERICAS FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 74. AMERICAS FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CLINIC SERVICES, 2018-2030 (USD MILLION)
TABLE 75. AMERICAS FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY HOME CARE TESTING, 2018-2030 (USD MILLION)
TABLE 76. AMERICAS FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY HOSPITAL SERVICES, 2018-2030 (USD MILLION)
TABLE 77. AMERICAS FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY INDEPENDENT LABORATORIES, 2018-2030 (USD MILLION)
TABLE 78. AMERICAS FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 79. UNITED STATES FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT METHOD, 2018-2030 (USD MILLION)
TABLE 80. UNITED STATES FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 81. UNITED STATES FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CRYOPRESERVATION, 2018-2030 (USD MILLION)
TABLE 82. UNITED STATES FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY FERTILITY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 83. UNITED STATES FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY SURGICAL INTERVENTION, 2018-2030 (USD MILLION)
TABLE 84. UNITED STATES FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 85. UNITED STATES FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY BLOOD DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 86. UNITED STATES FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY GENETIC TESTING, 2018-2030 (USD MILLION)
TABLE 87. UNITED STATES FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY ULTRASOUND IMAGING, 2018-2030 (USD MILLION)
TABLE 88. UNITED STATES FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 89. UNITED STATES FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CLINIC SERVICES, 2018-2030 (USD MILLION)
TABLE 90. UNITED STATES FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY HOME CARE TESTING, 2018-2030 (USD MILLION)
TABLE 91. UNITED STATES FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY HOSPITAL SERVICES, 2018-2030 (USD MILLION)
TABLE 92. UNITED STATES FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY INDEPENDENT LABORATORIES, 2018-2030 (USD MILLION)
TABLE 93. UNITED STATES FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 94. CANADA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT METHOD, 2018-2030 (USD MILLION)
TABLE 95. CANADA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 96. CANADA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CRYOPRESERVATION, 2018-2030 (USD MILLION)
TABLE 97. CANADA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY FERTILITY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 98. CANADA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY SURGICAL INTERVENTION, 2018-2030 (USD MILLION)
TABLE 99. CANADA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 100. CANADA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY BLOOD DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 101. CANADA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY GENETIC TESTING, 2018-2030 (USD MILLION)
TABLE 102. CANADA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY ULTRASOUND IMAGING, 2018-2030 (USD MILLION)
TABLE 103. CANADA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 104. CANADA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CLINIC SERVICES, 2018-2030 (USD MILLION)
TABLE 105. CANADA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY HOME CARE TESTING, 2018-2030 (USD MILLION)
TABLE 106. CANADA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY HOSPITAL SERVICES, 2018-2030 (USD MILLION)
TABLE 107. CANADA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY INDEPENDENT LABORATORIES, 2018-2030 (USD MILLION)
TABLE 108. MEXICO FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT METHOD, 2018-2030 (USD MILLION)
TABLE 109. MEXICO FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 110. MEXICO FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CRYOPRESERVATION, 2018-2030 (USD MILLION)
TABLE 111. MEXICO FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY FERTILITY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 112. MEXICO FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY SURGICAL INTERVENTION, 2018-2030 (USD MILLION)
TABLE 113. MEXICO FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 114. MEXICO FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY BLOOD DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 115. MEXICO FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY GENETIC TESTING, 2018-2030 (USD MILLION)
TABLE 116. MEXICO FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY ULTRASOUND IMAGING, 2018-2030 (USD MILLION)
TABLE 117. MEXICO FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 118. MEXICO FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CLINIC SERVICES, 2018-2030 (USD MILLION)
TABLE 119. MEXICO FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY HOME CARE TESTING, 2018-2030 (USD MILLION)
TABLE 120. MEXICO FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY HOSPITAL SERVICES, 2018-2030 (USD MILLION)
TABLE 121. MEXICO FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY INDEPENDENT LABORATORIES, 2018-2030 (USD MILLION)
TABLE 122. BRAZIL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT METHOD, 2018-2030 (USD MILLION)
TABLE 123. BRAZIL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 124. BRAZIL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CRYOPRESERVATION, 2018-2030 (USD MILLION)
TABLE 125. BRAZIL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY FERTILITY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 126. BRAZIL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY SURGICAL INTERVENTION, 2018-2030 (USD MILLION)
TABLE 127. BRAZIL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 128. BRAZIL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY BLOOD DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 129. BRAZIL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY GENETIC TESTING, 2018-2030 (USD MILLION)
TABLE 130. BRAZIL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY ULTRASOUND IMAGING, 2018-2030 (USD MILLION)
TABLE 131. BRAZIL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 132. BRAZIL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CLINIC SERVICES, 2018-2030 (USD MILLION)
TABLE 133. BRAZIL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY HOME CARE TESTING, 2018-2030 (USD MILLION)
TABLE 134. BRAZIL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY HOSPITAL SERVICES, 2018-2030 (USD MILLION)
TABLE 135. BRAZIL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY INDEPENDENT LABORATORIES, 2018-2030 (USD MILLION)
TABLE 136. ARGENTINA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT METHOD, 2018-2030 (USD MILLION)
TABLE 137. ARGENTINA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 138. ARGENTINA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CRYOPRESERVATION, 2018-2030 (USD MILLION)
TABLE 139. ARGENTINA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY FERTILITY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 140. ARGENTINA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY SURGICAL INTERVENTION, 2018-2030 (USD MILLION)
TABLE 141. ARGENTINA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 142. ARGENTINA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY BLOOD DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 143. ARGENTINA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY GENETIC TESTING, 2018-2030 (USD MILLION)
TABLE 144. ARGENTINA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY ULTRASOUND IMAGING, 2018-2030 (USD MILLION)
TABLE 145. ARGENTINA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 146. ARGENTINA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CLINIC SERVICES, 2018-2030 (USD MILLION)
TABLE 147. ARGENTINA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY HOME CARE TESTING, 2018-2030 (USD MILLION)
TABLE 148. ARGENTINA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY HOSPITAL SERVICES, 2018-2030 (USD MILLION)
TABLE 149. ARGENTINA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY INDEPENDENT LABORATORIES, 2018-2030 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT METHOD, 2018-2030 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CRYOPRESERVATION, 2018-2030 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY FERTILITY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY SURGICAL INTERVENTION, 2018-2030 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY BLOOD DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY GENETIC TESTING, 2018-2030 (USD MILLION)
TABLE 158. EUROPE, MIDDLE EAST & AFRICA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY ULTRASOUND IMAGING, 2018-2030 (USD MILLION)
TABLE 159. EUROPE, MIDDLE EAST & AFRICA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 160. EUROPE, MIDDLE EAST & AFRICA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CLINIC SERVICES, 2018-2030 (USD MILLION)
TABLE 161. EUROPE, MIDDLE EAST & AFRICA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY HOME CARE TESTING, 2018-2030 (USD MILLION)
TABLE 162. EUROPE, MIDDLE EAST & AFRICA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY HOSPITAL SERVICES, 2018-2030 (USD MILLION)
TABLE 163. EUROPE, MIDDLE EAST & AFRICA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY INDEPENDENT LABORATORIES, 2018-2030 (USD MILLION)
TABLE 164. EUROPE, MIDDLE EAST & AFRICA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 165. UNITED KINGDOM FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT METHOD, 2018-2030 (USD MILLION)
TABLE 166. UNITED KINGDOM FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 167. UNITED KINGDOM FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CRYOPRESERVATION, 2018-2030 (USD MILLION)
TABLE 168. UNITED KINGDOM FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY FERTILITY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 169. UNITED KINGDOM FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY SURGICAL INTERVENTION, 2018-2030 (USD MILLION)
TABLE 170. UNITED KINGDOM FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 171. UNITED KINGDOM FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY BLOOD DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 172. UNITED KINGDOM FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY GENETIC TESTING, 2018-2030 (USD MILLION)
TABLE 173. UNITED KINGDOM FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY ULTRASOUND IMAGING, 2018-2030 (USD MILLION)
TABLE 174. UNITED KINGDOM FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 175. UNITED KINGDOM FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CLINIC SERVICES, 2018-2030 (USD MILLION)
TABLE 176. UNITED KINGDOM FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY HOME CARE TESTING, 2018-2030 (USD MILLION)
TABLE 177. UNITED KINGDOM FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY HOSPITAL SERVICES, 2018-2030 (USD MILLION)
TABLE 178. UNITED KINGDOM FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY INDEPENDENT LABORATORIES, 2018-2030 (USD MILLION)
TABLE 179. GERMANY FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT METHOD, 2018-2030 (USD MILLION)
TABLE 180. GERMANY FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 181. GERMANY FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CRYOPRESERVATION, 2018-2030 (USD MILLION)
TABLE 182. GERMANY FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY FERTILITY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 183. GERMANY FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY SURGICAL INTERVENTION, 2018-2030 (USD MILLION)
TABLE 184. GERMANY FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 185. GERMANY FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY BLOOD DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 186. GERMANY FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY GENETIC TESTING, 2018-2030 (USD MILLION)
TABLE 187. GERMANY FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY ULTRASOUND IMAGING, 2018-2030 (USD MILLION)
TABLE 188. GERMANY FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 189. GERMANY FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CLINIC SERVICES, 2018-2030 (USD MILLION)
TABLE 190. GERMANY FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY HOME CARE TESTING, 2018-2030 (USD MILLION)
TABLE 191. GERMANY FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY HOSPITAL SERVICES, 2018-2030 (USD MILLION)
TABLE 192. GERMANY FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY INDEPENDENT LABORATORIES, 2018-2030 (USD MILLION)
TABLE 193. FRANCE FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT METHOD, 2018-2030 (USD MILLION)
TABLE 194. FRANCE FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 195. FRANCE FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CRYOPRESERVATION, 2018-2030 (USD MILLION)
TABLE 196. FRANCE FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY FERTILITY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 197. FRANCE FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY SURGICAL INTERVENTION, 2018-2030 (USD MILLION)
TABLE 198. FRANCE FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 199. FRANCE FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY BLOOD DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 200. FRANCE FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY GENETIC TESTING, 2018-2030 (USD MILLION)
TABLE 201. FRANCE FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY ULTRASOUND IMAGING, 2018-2030 (USD MILLION)
TABLE 202. FRANCE FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 203. FRANCE FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CLINIC SERVICES, 2018-2030 (USD MILLION)
TABLE 204. FRANCE FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY HOME CARE TESTING, 2018-2030 (USD MILLION)
TABLE 205. FRANCE FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY HOSPITAL SERVICES, 2018-2030 (USD MILLION)
TABLE 206. FRANCE FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY INDEPENDENT LABORATORIES, 2018-2030 (USD MILLION)
TABLE 207. RUSSIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT METHOD, 2018-2030 (USD MILLION)
TABLE 208. RUSSIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 209. RUSSIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CRYOPRESERVATION, 2018-2030 (USD MILLION)
TABLE 210. RUSSIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY FERTILITY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 211. RUSSIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY SURGICAL INTERVENTION, 2018-2030 (USD MILLION)
TABLE 212. RUSSIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 213. RUSSIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY BLOOD DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 214. RUSSIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY GENETIC TESTING, 2018-2030 (USD MILLION)
TABLE 215. RUSSIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY ULTRASOUND IMAGING, 2018-2030 (USD MILLION)
TABLE 216. RUSSIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 217. RUSSIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CLINIC SERVICES, 2018-2030 (USD MILLION)
TABLE 218. RUSSIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY HOME CARE TESTING, 2018-2030 (USD MILLION)
TABLE 219. RUSSIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY HOSPITAL SERVICES, 2018-2030 (USD MILLION)
TABLE 220. RUSSIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY INDEPENDENT LABORATORIES, 2018-2030 (USD MILLION)
TABLE 221. ITALY FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT METHOD, 2018-2030 (USD MILLION)
TABLE 222. ITALY FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 223. ITALY FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CRYOPRESERVATION, 2018-2030 (USD MILLION)
TABLE 224. ITALY FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY FERTILITY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 225. ITALY FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY SURGICAL INTERVENTION, 2018-2030 (USD MILLION)
TABLE 226. ITALY FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 227. ITALY FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY BLOOD DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 228. ITALY FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY GENETIC TESTING, 2018-2030 (USD MILLION)
TABLE 229. ITALY FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY ULTRASOUND IMAGING, 2018-2030 (USD MILLION)
TABLE 230. ITALY FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 231. ITALY FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CLINIC SERVICES, 2018-2030 (USD MILLION)
TABLE 232. ITALY FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY HOME CARE TESTING, 2018-2030 (USD MILLION)
TABLE 233. ITALY FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY HOSPITAL SERVICES, 2018-2030 (USD MILLION)
TABLE 234. ITALY FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY INDEPENDENT LABORATORIES, 2018-2030 (USD MILLION)
TABLE 235. SPAIN FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT METHOD, 2018-2030 (USD MILLION)
TABLE 236. SPAIN FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 237. SPAIN FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CRYOPRESERVATION, 2018-2030 (USD MILLION)
TABLE 238. SPAIN FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY FERTILITY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 239. SPAIN FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY SURGICAL INTERVENTION, 2018-2030 (USD MILLION)
TABLE 240. SPAIN FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 241. SPAIN FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY BLOOD DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 242. SPAIN FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY GENETIC TESTING, 2018-2030 (USD MILLION)
TABLE 243. SPAIN FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY ULTRASOUND IMAGING, 2018-2030 (USD MILLION)
TABLE 244. SPAIN FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 245. SPAIN FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CLINIC SERVICES, 2018-2030 (USD MILLION)
TABLE 246. SPAIN FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY HOME CARE TESTING, 2018-2030 (USD MILLION)
TABLE 247. SPAIN FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY HOSPITAL SERVICES, 2018-2030 (USD MILLION)
TABLE 248. SPAIN FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY INDEPENDENT LABORATORIES, 2018-2030 (USD MILLION)
TABLE 249. UNITED ARAB EMIRATES FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT METHOD, 2018-2030 (USD MILLION)
TABLE 250. UNITED ARAB EMIRATES FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 251. UNITED ARAB EMIRATES FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CRYOPRESERVATION, 2018-2030 (USD MILLION)
TABLE 252. UNITED ARAB EMIRATES FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY FERTILITY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 253. UNITED ARAB EMIRATES FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY SURGICAL INTERVENTION, 2018-2030 (USD MILLION)
TABLE 254. UNITED ARAB EMIRATES FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 255. UNITED ARAB EMIRATES FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY BLOOD DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 256. UNITED ARAB EMIRATES FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY GENETIC TESTING, 2018-2030 (USD MILLION)
TABLE 257. UNITED ARAB EMIRATES FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY ULTRASOUND IMAGING, 2018-2030 (USD MILLION)
TABLE 258. UNITED ARAB EMIRATES FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 259. UNITED ARAB EMIRATES FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CLINIC SERVICES, 2018-2030 (USD MILLION)
TABLE 260. UNITED ARAB EMIRATES FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY HOME CARE TESTING, 2018-2030 (USD MILLION)
TABLE 261. UNITED ARAB EMIRATES FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY HOSPITAL SERVICES, 2018-2030 (USD MILLION)
TABLE 262. UNITED ARAB EMIRATES FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY INDEPENDENT LABORATORIES, 2018-2030 (USD MILLION)
TABLE 263. SAUDI ARABIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT METHOD, 2018-2030 (USD MILLION)
TABLE 264. SAUDI ARABIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Female Infertility Diagnosis & Treatment market report include:
  • Merck KGaA
  • Ferring B.V.
  • Gedeon Richter Plc
  • CooperCompanies, Inc.
  • Vitrolife AB
  • Cook Medical LLC
  • Progyny, Inc.
  • Igenomix S.L.
  • Illumina, Inc.
  • Hamilton Thorne, Ltd.

Table Information

Report AttributeDetails
No. of Pages194
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 2.12 Billion
Forecasted Market Value ( USD ) by 2030 $ 3.14 Billion
Compound Annual Growth Rate8.1%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Female Infertility Diagnosis - Global Strategic Business Report - Product Image

Female Infertility Diagnosis - Global Strategic Business Report

  • Report
  • 176 Pages
  • Global
From
Female Infertility Market Report 2025 - Product Image

Female Infertility Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Female Infertility: Seven-Market Drug Forecast and Market Analysis - Product Image

Female Infertility: Seven-Market Drug Forecast and Market Analysis

  • Report
  • 112 Pages
  • Global
From
Female Infertility - Pipeline Insight, 2025 - Product Image

Female Infertility - Pipeline Insight, 2025

  • Drug Pipelines
  • 75 Pages
  • Global
From
Female Infertility: Epidemiology Forecast to 2033 - Product Image

Female Infertility: Epidemiology Forecast to 2033

  • Report
  • 38 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.